Civic IQ
SUPPLIESAMENDED

Harris Health Board of Trustees Meeting Agenda May 2026

Cepheid GeneXpert consumables funding increased

$523,390Harris HealthCEPHEIDMay 13, 2026

Trusted by teams at

Motive logo
Veritone logo
TerraCycle logo
Cyvl logo
WithersRavenel logo
Derivita logo
Comcate logo
SafeTouch logo
IANS Research logo
Motive logo
Veritone logo
TerraCycle logo
Cyvl logo
WithersRavenel logo
Derivita logo
Comcate logo
SafeTouch logo
IANS Research logo
Motive logo
Veritone logo
TerraCycle logo
Cyvl logo
WithersRavenel logo
Derivita logo
Comcate logo
SafeTouch logo
IANS Research logo
Motive logo
Veritone logo
TerraCycle logo
Cyvl logo
WithersRavenel logo
Derivita logo
Comcate logo
SafeTouch logo
IANS Research logo

Description

Harris Health will ratify a $523,390 funding increase to its sole source agreement with Cepheid for GeneXpert reagents, test cartridges, and consumables from April 18, 2025 through April 17, 2026. The adjustment supports higher testing volumes.

Contract Details

Contract Amount

$523,390

Vendor

CEPHEID

Agency

Harris Health, TX

Contract Type

SUPPLIES

Document Date

May 13, 2026

Contract Term

April 18, 2025 through April 17, 2026

Renewal Date

2026-04-17

Renewal Info

Sole source consumables contract in effect through April 17, 2026; future renewal terms are not specified in the agenda.

Bring us your territory.
We'll show you what is forming.

See live SLED buying signals, source docs, decision-makers, contract context, and the next step into your CRM or pipeline.

Try Civic IQ for free